Strained ruthenium complexes are potent light-activated anticancer agents.
about
Transition Metal Intercalators as Anticancer Agents-Recent AdvancesRecent Advances of Light-Mediated Theranostics.Antitumor activity of new enantiopure pybox-ruthenium complexes.A Family of Potent Ru(II) Photosensitizers with Enhanced DNA Intercalation: Bimodal Photokillers.Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.Modifying charge and hydrophilicity of simple Ru(II) polypyridyl complexes radically alters biological activities: old complexes, surprising new tricks.Visible light photoredox catalysis with transition metal complexes: applications in organic synthesis.De novo generation of singlet oxygen and ammine ligands by photoactivation of a platinum anticancer complex.Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapyUltrafast photo-induced ligand solvolysis of cis-[Ru(bipyridine)2(nicotinamide)2](2+): experimental and theoretical insight into its photoactivation mechanism.Excited state investigation of a new Ru(II) complex for dual reactivity with low energy light.Receptor selective ruthenium-somatostatin photosensitizer for cancer targeted photodynamic applications.Synthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging.Light-activated protein inhibition through photoinduced electron transfer of a ruthenium(II)-cobalt(III) bimetallic complexPhotochemistry of RuII 4,4'-bi-1,2,3-triazolyl (btz) complexes: crystallographic characterization of the photoreactive ligand-loss intermediate trans-[Ru(bpy)(κ2-btz)(κ1-btz)(NCMe)]2+Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity.Red Light Activation of Ru(II) Polypyridyl Prodrugs via Triplet-Triplet Annihilation Upconversion: Feasibility in Air and through Meat.Triplet-triplet annihilation upconversion followed by FRET for the red light activation of a photodissociative ruthenium complex in liposomes.Influence of the Steric Bulk and Solvent on the Photoreactivity of Ruthenium Polypyridyl Complexes Coordinated to l-Proline.New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generationLight-Sensitive Ruthenium Complex-Loaded Cross-linked Polymeric Nanoassemblies for the Treatment of CancerSelective Photodissociation of Acetonitrile Ligands in Ruthenium Polypyridyl Complexes Studied by Density Functional Theory.New Ru(II) Complex for Dual Activity: Photoinduced Ligand Release and (1)O2 Production.Effects of Methyl Substitution in Ruthenium Tris(2-pyridylmethyl)amine Photocaging Groups for Nitriles.Ultrafast in cellulo photoinduced dynamics processes of the paradigm molecular light switch [Ru(bpy)2dppz](2.).An in vitro cell irradiation protocol for testing photopharmaceuticals and the effect of blue, green, and red light on human cancer cell lines.Ultrafast transient IR spectroscopy and DFT calculations of ruthenium(ii) polypyridyl complexesCombatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity.A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin.Ligand functionalization as a deactivation pathway in a fac-Ir(ppy)3-mediated radical additionPhototoxicity of strained Ru(ii) complexes: is it the metal complex or the dissociating ligand?Anticancer Activity Studies of Ruthenium(II) Complex Toward Human Osteosarcoma HOS Cells.A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy.Cobalt(III) Chaperone Complexes of Curcumin: Photoreduction, Cellular Accumulation and Light-Selective Toxicity towards Tumour Cells.A luminescent ruthenium(II) complex for light-triggered drug release and live cell imaging.Two novel BODIPY-Ru(ii) arene dyads enabling effective photo-inactivation against cancer cells.Ruthenium complex Λ-WH0402 induces hepatocellular carcinoma LM6 (HCCLM6) cell death by triggering the Beclin-1-dependent autophagy pathway.Fine control on the photochemical and photobiological properties of Ru(II) arene complexes.A novel class of ruthenium-based photosensitizers effectively kills in vitro cancer cells and in vivo tumors.
P2860
Q28077365-C7C246F9-FB0D-4EC0-9B0D-58C9E48A16CAQ28077517-132DB9D3-DB16-4E5C-AA30-F8182BB467B9Q30660221-B9DABEFB-F7E3-4AC3-8EF9-32007BED0F8DQ30977137-35E827AE-C681-4F49-967A-88229CC3D93AQ33670035-75FF03FA-8228-48FE-9D4B-C96F3A641A93Q33862903-96418296-6FA8-46FB-BA17-BD674252FDC9Q34293548-D9A100B5-B771-4566-B843-3C0E4B42C974Q34333964-1D2722FC-803F-4D90-A026-841552FAA1CBQ34503145-69E6D3FE-284A-43B4-AD10-B7D9736B54BFQ35128594-9DE13A93-6B5D-4A28-ADAC-A31ABCB799DEQ35212794-3D35EB93-C796-4FD1-8C12-386856ADE0F4Q35602539-A9FD400C-9899-4383-958D-F164C69577A3Q35685706-41C37BEA-96F0-46C3-875E-DAAE98C18FE8Q35786129-E406E31B-B52D-4228-82A7-3FEF16205C8CQ35805471-56956E61-A808-4A4F-BE5D-12DCFBB9D4E6Q35863531-91153EC9-E2D5-4DE9-B138-434E88706A6AQ36102019-1570A1C3-1560-46C8-A4B9-F920B0763C0AQ36181076-9F240271-935A-4500-B852-E3E3ADCCDDF7Q36272376-D33C1B4F-935B-4408-867A-758DE492850EQ36345759-A7A0FA89-F9C7-4B5C-8D70-4B4884DAE221Q36533554-59E1A3BF-0220-4017-8AE0-94B7343AEBE9Q36539791-DEB49F24-079B-4354-A9B0-F4E78EC8CB2AQ36549488-21A86024-C795-46F8-8AF6-1C85A3185C3DQ36642693-3F16A97D-3B2B-4F07-B55E-7A1B0A56DC19Q37138342-F48F82F6-33B4-4D26-9333-71E86C568365Q37267323-E79AD1B4-BF81-4023-B779-4264C2D968C5Q37300322-75858DD2-141A-4FC4-980F-CCC2F715C005Q37641185-37FD0D3B-AC4E-49A1-AD44-756C698ABFF3Q37720315-BE7A4653-E32B-4C0C-8EBB-9476B609D38DQ38294800-A0BE5506-AA1D-4BD2-B79A-FBE2D3F44C5EQ38679889-F336C8BB-E985-451A-AFC0-5537BAC8E6E6Q38696298-77CA095B-DD3F-4898-BCF4-8814EB5AC44FQ38783886-97DEEB1A-8182-4368-AF33-F3C497F6EBC9Q38788535-92F1E691-4D63-47B6-9ED8-285B4D4EF657Q38827618-51BBCD2B-0D44-4984-A11E-C82764F2BF51Q38845855-09D26897-086A-4D5C-B1CD-A93177F9AC5CQ38862566-2E09358F-8D16-4F9E-8982-50D0E100ED01Q38894897-9CF0A487-2B93-40A7-96D3-44D5907B0042Q38896587-FCF8C90F-052C-4306-B1F1-7B89F0B27953Q38911313-ADE26B5C-522D-4DB6-B410-8F195E7EB7EA
P2860
Strained ruthenium complexes are potent light-activated anticancer agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Strained ruthenium complexes are potent light-activated anticancer agents.
@en
Strained ruthenium complexes are potent light-activated anticancer agents.
@nl
type
label
Strained ruthenium complexes are potent light-activated anticancer agents.
@en
Strained ruthenium complexes are potent light-activated anticancer agents.
@nl
prefLabel
Strained ruthenium complexes are potent light-activated anticancer agents.
@en
Strained ruthenium complexes are potent light-activated anticancer agents.
@nl
P2093
P356
P1476
Strained ruthenium complexes are potent light-activated anticancer agents.
@en
P2093
Brock S Howerton
David K Heidary
Edith C Glazer
P304
P356
10.1021/JA3009677
P407
P577
2012-05-11T00:00:00Z